🔎 Trials Near Me

Hem › Akut myeloid leukemi › New Jersey › Edison

Kliniska studier för Akut myeloid leukemi i Edison, NJ

20 studier för Akut myeloid leukemi söker deltagare vid platser i och runt Edison (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

RekryterarFas 1
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi bort
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi bort
Ålder 18 och äldre · Alla kön · Uppdaterad 1 okt. 2026 · NCT06484062

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

RekryterarFas 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi bort
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi bort
Ålder 18 till 59 · Alla kön · Uppdaterad 28 sep. 2026 · NCT05554393

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

RekryterarFas 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi bort
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi bort
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT05564390

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

RekryterarFas 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi bort
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi bort
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT06317649

A Study of CRD3874-SI in People With Leukemia

RekryterarFas 1
  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi bort
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07661095

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

RekryterarFas 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi bort
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi bort
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

RekryterarFas 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi bort
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi bort
Ålder 18 till 59 · Alla kön · Uppdaterad 22 sep. 2026 · NCT05554406

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

RekryterarFas 3
  • Saint Peter's University Hospital, New Brunswick · 3 mi bort
  • Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi bort
6 Months – 21 Years · Alla kön · Uppdaterad 17 sep. 2026 · NCT04293562

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

RekryterarFas 1/2
  • Saint Peter's University Hospital, New Brunswick · 3 mi bort
  • Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi bort
Upp till ålder 22 · Alla kön · Uppdaterad 25 aug. 2026 · NCT04726241

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

RekryterarFas 3
  • Rutgers Biomedical and Health Sciences, New Brunswick · 3 mi bort
Ålder 18 och äldre · Alla kön · Uppdaterad 20 aug. 2026 · NCT07007312

A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia

RekryterarFas 2
  • Memoral Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi bort
Ålder 60 och äldre · Alla kön · Uppdaterad 17 juli 2026 · NCT07392242

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RekryterarObservationsstudie
  • Robert Wood Johnson/Cancer Institute of New Jersey, New Brunswick · 3 mi bort
Alla åldrar · Alla kön · Uppdaterad 6 juli 2026 · NCT01351545

A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)

RekryterarFas 1
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi bort
Ålder 18 och äldre · Alla kön · Uppdaterad 22 juni 2026 · NCT05756777

A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia

RekryterarFas 1
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi bort
Ålder 1 och äldre · Alla kön · Uppdaterad 22 juni 2026 · NCT06017258

A Study of Revumenib and Mezigdomide in People With Leukemia

RekryterarFas 1/2
  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi bort
Ålder 12 och äldre · Alla kön · Uppdaterad 22 juni 2026 · NCT07356154

A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia

RekryterarFas 1
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi bort
Ålder 18 till 70 · Alla kön · Uppdaterad 17 juni 2026 · NCT07011004

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

RekryterarFas 1/2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi bort
Ålder 12 och äldre · Alla kön · Uppdaterad 24 mars 2026 · NCT04988555

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

RekryterarFas 1
  • Rutgers Cancer Institute, New Brunswick · 3 mi bort
Ålder 18 och äldre · Alla kön · Uppdaterad 13 mars 2026 · NCT05735184

A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia

RekryterarFas 1
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi bort
Ålder 18 och äldre · Alla kön · Uppdaterad 10 mars 2026 · NCT05748197

A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)

RekryterarFas 2
  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi bort
Ålder 18 och äldre · Alla kön · Uppdaterad 24 feb. 2026 · NCT06773208

Akut myeloid leukemi-studier i andra städer

Andra studier i Edison

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.